Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 201 | RGNX | REGENXBIO INC | Healthcare | 49,129.0 | $589K | 0.14% | +29K | +149.9% | $11.98 | -7.6% |
| 202 | — | OAKTREE SPECIALTY LENDING | — | 46,824.0 | $559K | 0.13% | -18K | -27.5% | $11.94 | — |
| 203 | QURE | UNIQURE NV | Healthcare | 11,867.0 | $547K | 0.13% | -2K | -15.1% | $46.06 | +2.9% |
| 204 | VVR | INVESCO SR INCOME TR | Financial Services | 176,549.0 | $530K | 0.12% | -27K | -13.1% | $3.00 | -2.3% |
| 205 | SCM | STELLUS CAP INVT CORP | Financial Services | 62,135.0 | $523K | 0.12% | +1K | +2.4% | $8.42 | +1.9% |
| 206 | SPMC | SOUND POINT MERIDIAN CAP INC | Financial Services | 52,537.0 | $520K | 0.12% | -15K | -21.8% | $9.90 | -7.2% |
| 207 | CCAP | CRESCENT CAP BDC INC | Financial Services | 47,621.0 | $520K | 0.12% | +3K | +6.0% | $10.92 | -0.9% |
| 208 | MBX | MBX BIOSCIENCES INC | Healthcare | 9,215.0 | $509K | 0.12% | +84.0 | +0.9% | $55.20 | +20.5% |
| 209 | — | MONOPAR THERAPEUTICS INC | — | 5,474.0 | $507K | 0.12% | +2K | +49.8% | $92.59 | — |
| 210 | CGBD | CARLYLE SECURED LENDING INC | Financial Services | 46,857.0 | $493K | 0.12% | -9K | -15.9% | $10.53 | +6.5% |
| 211 | FDMT | 4D MOLECULAR THERAPEUTICS IN | Healthcare | 37,055.0 | $493K | 0.12% | +12K | +47.3% | $13.30 | +10.7% |
| 212 | — | APOGEE THERAPEUTICS INC | — | 3,705.0 | $492K | 0.12% | +167.0 | +4.7% | $132.73 | — |
| 213 | ABCL | ABCELLERA BIOLOGICS INC | Healthcare | 62,442.0 | $490K | 0.11% | -13K | -17.1% | $7.85 | +41.7% |
| 214 | NMFC | NEW MTN FIN CORP | Financial Services | 67,254.0 | $482K | 0.11% | -22K | -24.8% | $7.17 | +3.9% |
| 215 | AKTS | AKTIS ONCOLOGY INC | Healthcare | 14,920.0 | $481K | 0.11% | NEW | — | $32.23 | -22.4% |
| 216 | FSCO | FS CREDIT OPPORTUNITIES CORP | Financial Services | 96,005.0 | $479K | 0.11% | +4K | +4.5% | $4.99 | +3.2% |
| 217 | JBIO | JADE BIOSCIENCES INC | Healthcare | 21,329.0 | $474K | 0.11% | +3K | +17.2% | $22.22 | +6.0% |
| 218 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 19,304.0 | $468K | 0.11% | +5K | +35.0% | $24.26 | +11.0% |
| 219 | SAR | SARATOGA INVT CORP | Financial Services | 20,757.0 | $463K | 0.11% | -5K | -19.4% | $22.31 | -16.2% |
| 220 | MGTX | MEIRAGTX HLDGS PLC | Healthcare | 34,119.0 | $461K | 0.11% | +4K | +11.6% | $13.51 | +2.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%